48 results on '"Rodriguez, G. I."'
Search Results
2. Genotypic and allelic frequencies of SULT1A1 polymorphisms in women receiving adjuvant tamoxifen therapy
3. Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeks*
4. Herpetogramma bipunctalis (Lepidoptera: Crambidae) biology and techniques for rearing on leaves of the blackberry (Rubus spp., Rosaceae)
5. Development of Anastrepha fraterculus (Diptera: Tephritidae) Related to the Phenology of Blueberry, Blackberry, Strawberry Guava, and Surinam Cherry Fruits
6. Paleomagnetic results from rhyolites (Early Cretaceous?) and andesite dikes at two localities in the Ocana area, northern Santander Massif, Colombia
7. A meta-analysis of results from two randomized, double-blind studies of denosumab versus zoledronic acid (ZA) for treatment of bone metastases.
8. An open-label randomized phase II trial of belinostat (PXD101) in combination with carboplatin and paclitaxel (BelCaP) compared to carboplatin and paclitaxel in patients with previously untreated carcinoma of unknown primary.
9. Relationship between CYP2D6 and estrogen receptor alpha polymorphisms on tamoxifen metabolism in adjuvant breast cancer treatment
10. Phase II trial of trastuzumab and paclitaxel or docetaxel administered every 3 weeks to patients receiving a first treatment for HER2+ metastatic breast cancer
11. Weekly paclitaxel/estramustine phosphate plus carboplatin administered either weekly or every 4 weeks in the treatment of hormone refractory prostate cancer (HRPC): A randomized phase II trial of the Minnie Pearl Cancer Research Network
12. Phase I and pharmacologic study of oral topotecan administered twice daily for 21 days to adult patients with solid tumors.
13. Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer.
14. A Phase II Trial of DaunoXome, Liposome- Encapsulated Daunorubicin, in Patients with Metastatic Adenocarcinoma of the Colon
15. A RANDOMIZED PHASE I TRIAL OF ETOPOSIDE (VP-16) AND GM-CSF FOR REFRACTORY SOLID CANCERS
16. Phase I and pharmacokinetic trial of weekly CPT-11.
17. Effect of ingested snakeweed (Gutierrezia microcephala) foliage on reproduction, semen quality, and serum clinical profiles of male rats1
18. Single daily dose amikacin in paediatric patients with severe Gram-negative infections
19. A phase I and pharmacokinetics study of 2-chlorodeoxyadenosine in patients with solid tumors.
20. Evaluation of 96-hour infusion fluorouracil plus cisplatin in combination with alpha interferon for patients with advanced squamous cell carcinoma of the head and neck: a Southwest Oncology Group study.
21. Five Days of Oral Topotecan (Hycamtin[R]), a Phase I and Pharmacological Study in Adult Patients with Solid Tumours
22. Tectonic implications of Cretaceous-Pliocene fission-track ages from rocks of the circum-Maracaibo Basin region of western Venezuela and eastern Colombia
23. New anticancer agents
24. New anticancer agents
25. A phase I and pharmacokinetic study of losoxantrone and paclitaxel in patients with advanced solid tumors
26. Zircon U-Pb age of the Paramo Rico tonalite-granodiorite, Santander Massif (Cordillera Oriental, Colombia) and its geotectonic significance
27. Impacts of small-scale chicken farming activity on antimicrobial-resistant Escherichia coli carriage in backyard chickens and children in rural Ecuador.
28. A phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer.
29. Phase I and pharmacokinetic trial of oral irinotecan administered daily for 5 days every 3 weeks in patients with solid tumors.
30. Phase II trial of docetaxel for cholangiocarcinoma.
31. A phase I and pharmacokinetic study of losoxantrone and paclitaxel in patients with advanced solid tumors.
32. A comparison of clinical pharmacodynamics of different administration schedules of oral topotecan (Hycamtin)
33. Phase I trial of paclitaxel and gemcitabine administered every two weeks in patients with refractory solid tumors.
34. Oral topotecan given once or twice daily for ten days: a phase I pharmacology study in adult patients with solid tumors.
35. A bioavailability and pharmacokinetic study of oral and intravenous hydroxyurea.
36. A phase I and pharmacokinetic trial of terephthalamidine (NSC 57155) as a 120-hour continuous infusion.
37. A phase I trial of vinorelbine in combination with mitoxantrone in patients with refractory solid tumors.
38. Phase I study with the DNA sequence-specific agent adozelesin.
39. New anticancer agents.
40. A randomized phase I study of oral etoposide with or without granulocyte-macrophage colony-stimulating factor for the treatment of patients with advanced cancer.
41. New anticancer agents.
42. A phase II trial of ilmofosine in non-small cell bronchogenic carcinoma.
43. Evaluation of topotecan in patients with recurrent for metastatic squamous cell carcinoma of the head and neck. A phase II Southwest Oncology Group study.
44. New anticancer agents.
45. New anticancer agents.
46. New anticancer agents.
47. New anticancer agents.
48. New anticancer agents.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.